People | June 08, 2022
Prolacta Bioscience appoints David Steinberg as CFO
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Auld is a seasoned Financial Executive with over 30 years of relevant experience
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The commercial production in the SML was started in November 1989.
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
EBITDA before special items decreases to €4.08 billion (7.4%)
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Delivers robust earnings performance, successfully navigating a dynamic environment
Subscribe To Our Newsletter & Stay Updated
